210 related articles for article (PubMed ID: 33622375)
1. A preliminary study of micro-RNAs as minimally invasive biomarkers for the diagnosis of prostate cancer patients.
Giglio S; De Nunzio C; Cirombella R; Stoppacciaro A; Faruq O; Volinia S; Baldassarre G; Tubaro A; Ishii H; Croce CM; Vecchione A
J Exp Clin Cancer Res; 2021 Feb; 40(1):79. PubMed ID: 33622375
[TBL] [Abstract][Full Text] [Related]
2. Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role.
Cochetti G; Poli G; Guelfi G; Boni A; Egidi MG; Mearini E
Onco Targets Ther; 2016; 9():7545-7553. PubMed ID: 28008272
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs as biomarkers for prostate cancer prognosis: a systematic review and a systematic reanalysis of public data.
Rana S; Valbuena GN; Curry E; Bevan CL; Keun HC
Br J Cancer; 2022 Feb; 126(3):502-513. PubMed ID: 35022525
[TBL] [Abstract][Full Text] [Related]
4. Biomarker Potential of Plasma MicroRNA-150-5p in Prostate Cancer.
Paunescu IA; Bardan R; Marcu A; Nitusca D; Dema A; Negru S; Balacescu O; Balacescu L; Cumpanas A; Sirbu IO; Petrut B; Seclaman E; Marian C
Medicina (Kaunas); 2019 Sep; 55(9):. PubMed ID: 31484346
[No Abstract] [Full Text] [Related]
5. miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer.
Ghorbanmehr N; Gharbi S; Korsching E; Tavallaei M; Einollahi B; Mowla SJ
Prostate; 2019 Jan; 79(1):88-95. PubMed ID: 30194772
[TBL] [Abstract][Full Text] [Related]
6. Small extracellular vesicle-encapsulated miR-181b-5p, miR-222-3p and let-7a-5p: Next generation plasma biopsy-based diagnostic biomarkers for inflammatory breast cancer.
Ahmed SH; Espinoza-Sánchez NA; El-Damen A; Fahim SA; Badawy MA; Greve B; El-Shinawi M; Götte M; Ibrahim SA
PLoS One; 2021; 16(4):e0250642. PubMed ID: 33901254
[TBL] [Abstract][Full Text] [Related]
7. miRNAs expression signature potentially associated with lymphatic dissemination in locally advanced prostate cancer.
Pudova EA; Krasnov GS; Nyushko KM; Kobelyatskaya AA; Savvateeva MV; Poloznikov AA; Dolotkazin DR; Klimina KM; Guvatova ZG; Simanovsky SA; Gladysh NS; Tokarev AT; Melnikova NV; Dmitriev AA; Alekseev BY; Kaprin AD; Kiseleva MV; Snezhkina AV; Kudryavtseva AV
BMC Med Genomics; 2020 Sep; 13(Suppl 8):129. PubMed ID: 32948204
[TBL] [Abstract][Full Text] [Related]
8. Challenges in Cancer Biomarker Discovery Exemplified by the Identification of Diagnostic MicroRNAs in Prostate Tissues.
Ambrozkiewicz F; Karczmarski J; Kulecka M; Paziewska A; Cybulska M; Szymanski M; Dobruch J; Antoniewicz A; Mikula M; Ostrowski J
Biomed Res Int; 2020; 2020():9086829. PubMed ID: 32462034
[TBL] [Abstract][Full Text] [Related]
9. Serum Levels of miR-223-3p and miR-223-5p in Prostate Diseases.
Dülgeroğlu Y; Eroğlu O
Microrna; 2020; 9(4):303-309. PubMed ID: 33155933
[TBL] [Abstract][Full Text] [Related]
10. Plasma microRNA ratios associated with breast cancer detection in a nested case-control study from a mammography screening cohort.
Chiorino G; Petracci E; Sehovic E; Gregnanin I; Camussi E; Mello-Grand M; Ostano P; Riggi E; Vergini V; Russo A; Berrino E; Ortale A; Garena F; Venesio T; Gallo F; Favettini E; Frigerio A; Matullo G; Segnan N; Giordano L
Sci Rep; 2023 Jul; 13(1):12040. PubMed ID: 37491482
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and Prognostic MicroRNA Biomarkers for Prostate Cancer in Cell-free Urine.
Fredsøe J; Rasmussen AKI; Thomsen AR; Mouritzen P; Høyer S; Borre M; Ørntoft TF; Sørensen KD
Eur Urol Focus; 2018 Dec; 4(6):825-833. PubMed ID: 28753866
[TBL] [Abstract][Full Text] [Related]
12. Circulating microRNAs combined with PSA for accurate and non-invasive prostate cancer detection.
Mello-Grand M; Gregnanin I; Sacchetto L; Ostano P; Zitella A; Bottoni G; Oderda M; Marra G; Munegato S; Pardini B; Naccarati A; Gasparini M; Gontero P; Chiorino G
Carcinogenesis; 2019 Apr; 40(2):246-253. PubMed ID: 30452625
[TBL] [Abstract][Full Text] [Related]
13. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Value of Peripheral Blood miR-374b-5p in Patients with Prostate Cancer.
Pang C; Song X; Fu C; Zhang Y; Zhang Y; Liu M
Clin Lab; 2020 Jan; 66(1):. PubMed ID: 32013356
[TBL] [Abstract][Full Text] [Related]
15. Discovery and Validation of Serum MicroRNAs as Early Diagnostic Biomarkers for Prostate Cancer in Chinese Population.
Lyu J; Zhao L; Wang F; Ji J; Cao Z; Xu H; Shi X; Zhu Y; Zhang C; Guo F; Yang B; Sun Y
Biomed Res Int; 2019; 2019():9306803. PubMed ID: 31534967
[TBL] [Abstract][Full Text] [Related]
16. Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone.
Salido-Guadarrama AI; Morales-Montor JG; Rangel-Escareño C; Langley E; Peralta-Zaragoza O; Cruz Colin JL; Rodriguez-Dorantes M
Mol Med Rep; 2016 Jun; 13(6):4549-60. PubMed ID: 27081843
[TBL] [Abstract][Full Text] [Related]
17. Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis.
Barceló M; Castells M; Bassas L; Vigués F; Larriba S
Sci Rep; 2019 Sep; 9(1):13772. PubMed ID: 31551516
[TBL] [Abstract][Full Text] [Related]
18. A Panel of MicroRNAs as Diagnostic Biomarkers for the Identification of Prostate Cancer.
Daniel R; Wu Q; Williams V; Clark G; Guruli G; Zehner Z
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28621736
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic micro-RNAs in ischaemic stroke due to carotid artery stenosis and in acute coronary syndrome: a four-year prospective study.
Gacoń J; Badacz R; Stępień E; Karch I; Enguita FJ; Żmudka K; Przewłocki T; Kabłak-Ziembicka A
Kardiol Pol; 2018; 76(2):362-369. PubMed ID: 29350392
[TBL] [Abstract][Full Text] [Related]
20. Potential plasma microRNAs signature miR-190b-5p, miR-215-5p and miR-527 as non-invasive biomarkers for prostate cancer.
Khan MM; Serajuddin M; Bharadwaj M
Biomarkers; 2023 Mar; 28(2):227-237. PubMed ID: 36644827
[No Abstract] [Full Text] [Related]
[Next] [New Search]
